Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status

The ε4 polymorphism of the APOE gene confers a substantially increased risk of developing Alzheimer's disease. However, the influence of the ε4 allele on age-related cognitive functioning is more contentious. Previously, we demonstrated relatively little evidence for a role of the ε4 allele on baseline cognitive performance in older adults in the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Ageing (Foster et al., 2013). We here investigated whether the APOE ε4 allele influenced cognitive status over time when the AIBL cohort was studied longitudinally over a 3-year period. The AIBL neuropsychological test battery was administered at baseline, after 18 months and again after 36 months. Participants comprised 764 Healthy Controls and 131 Mild Cognitively Impaired individuals enrolled in the AIBL Study of Ageing. We compared individuals within each group with and without an ε4 allele. Healthy Controls with an ε4 allele manifested a modest acceleration in cognitive decline over 36 months on measures of verbal episodic memory. By contrast, Mild Cognitively Impaired individuals with an ε4 allele showed increased cognitive decline across a range of cognitive tasks, putatively reflecting early cognitive signs of Alzheimer's disease. Given the long prodromal period that has been noted in late onset Alzheimer's disease, we suggest that these findings are consistent with a prodromal account rather than a phenotypic account of ε4-related cognitive ageing.

[1]  David A Bennett,et al.  The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. , 2002, Archives of neurology.

[2]  Andrew Gelman,et al.  Data Analysis Using Regression and Multilevel/Hierarchical Models , 2006 .

[3]  R. Petersen,et al.  Aging, Memory, and Mild Cognitive Impairment , 1997, International Psychogeriatrics.

[4]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Snyder,et al.  APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease , 2015, Neurobiology of Aging.

[6]  C. Rowe,et al.  Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults , 2012, Neurology.

[7]  David Poeppel,et al.  Prefrontal cortex asymmetry for memory encoding of words and abstract shapes. , 2004, Cerebral cortex.

[8]  R. Martins,et al.  Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. , 2013, Brain : a journal of neurology.

[9]  Zhiyong Zhang,et al.  Investigating Ceiling Effects in Longitudinal Data Analysis , 2008, Multivariate behavioral research.

[10]  K. Warner Schaie,et al.  “When does age-related cognitive decline begin?” Salthouse again reifies the “cross-sectional fallacy” , 2009, Neurobiology of Aging.

[11]  O. Spreen,et al.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .

[12]  H. Jacqmin-Gadda,et al.  Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[13]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[14]  H. Amièva,et al.  Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms , 2008, Annals of neurology.

[15]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[16]  Eve H. Limbrick-Oldfield,et al.  Differential Patterns of Prefrontal MEG Activation during Verbal & Visual Encoding and Retrieval , 2013, PloS one.

[17]  Martyn Plummer,et al.  Bayesian Graphical Models using MCMC , 2016 .

[18]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[19]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[20]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[21]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[22]  S. Rapcsak,et al.  Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers , 2011, Neurology.

[23]  J. Foster,et al.  The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults , 2013, Front. Aging Neurosci..

[24]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[25]  Andrew Gelman,et al.  Why We (Usually) Don't Have to Worry About Multiple Comparisons , 2009, 0907.2478.

[26]  L. Baxter,et al.  Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele , 2004, Neurology.

[27]  G. Alexander,et al.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. , 2009, The New England journal of medicine.

[28]  Eric M Reiman,et al.  Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. , 2007, Archives of neurology.

[29]  Gabriel Leonard,et al.  Frontal-lobe contribution to recency judgements , 1991, Neuropsychologia.

[30]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[31]  Martyn Plummer,et al.  JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling , 2003 .

[32]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[33]  Olivier Salvado,et al.  Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.

[34]  C. Rowe,et al.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.

[35]  David Ruppert,et al.  Bayesian Models for Multiple Outcomes Nested in Domains , 2009, Biometrics.

[36]  J. M. Guralnik,et al.  The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging , 2003 .

[37]  P. Maruff,et al.  The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment , 2000, Neuroscience & Biobehavioral Reviews.

[38]  J. Kruschke.  Doing Bayesian Data Analysis: A Tutorial with R and BUGS , 2010 .

[39]  W. Wong,et al.  The calculation of posterior distributions by data augmentation , 1987 .

[40]  Jeremy MG Taylor,et al.  Robust Statistical Modeling Using the t Distribution , 1989 .

[41]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[42]  C. Rowe,et al.  Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study , 2011, Neuropsychologia.

[43]  J. Kruschke.  Bayesian estimation supersedes the t test. , 2013, Journal of experimental psychology. General.

[44]  G. Alexander,et al.  Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[45]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[46]  M. Albert,et al.  Longitudinal change in cognitive performance among individuals with mild cognitive impairment. , 2007, Neuropsychology.

[47]  H. Christensen,et al.  ' s response to reviews Title : The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample , 2008 .

[48]  J. Tobin.  Estimation of Relationships for Limited Dependent Variables , 1958 .

[49]  M. W. Riley.  AGING AND COHORT SUCCESSION: INTERPRETATIONS AND MISINTERPRETATIONS , 1973 .

[50]  D. Rubin,et al.  Inference from Iterative Simulation Using Multiple Sequences , 1992 .